Cargando…
The Interface of Therapeutics and Genomics in Cardiovascular Medicine
Pharmacogenomics has a burgeoning role in cardiovascular medicine, from warfarin dosing to antiplatelet choice, with recent developments in sequencing bringing the promise of personalised medicine ever closer to the bedside. Further scientific evidence, real-world clinical trials, and economic model...
Autores principales: | Magavern, E. F., Kaski, J. C., Turner, R. M., Janmohamed, A., Borry, P., Pirmohamed, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851637/ https://www.ncbi.nlm.nih.gov/pubmed/33528719 http://dx.doi.org/10.1007/s10557-021-07149-3 |
Ejemplares similares
-
Military genomics: a perspective on the successes and challenges of genomic medicine in the Armed Services
por: De Castro, Mauricio J., et al.
Publicado: (2017) -
Therapeutic Potential of Senolytics in Cardiovascular Disease
por: Dookun, Emily, et al.
Publicado: (2020) -
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
por: Glerup, Simon, et al.
Publicado: (2017) -
Genomic medicine and data sharing
por: Raza, Sobia, et al.
Publicado: (2017) -
Sensory mechanotransduction at membrane-matrix interfaces
por: Poole, Kate, et al.
Publicado: (2014)